Source link : https://www.newshealth.biz/health-news/glp-1-agent-may-hold-opioid-use-disorder-benefit/
Semaglutide (Ozempic, Wegovy) may help reduce the risk of an opioid overdose in certain people, an emulation target trial suggested. Over a 1-year follow-up, people with comorbid type 2 diabetes and opioid use disorder (OUD) who took the GLP-1 receptor agonist for their diabetes had a significantly lower risk of an opioid overdose compared with […]
Author : News Health
Publish date : 2024-09-26 18:57:40
Copyright for syndicated content belongs to the linked Source.
Categories